Forskningsradar
← Hälsa & medicin
Hälsa & medicin 4.1

Blood cancer patients face heightened COVID-19 risk, study warns

A European registry analysis found that patients with Philadelphia-negative myeloproliferative neoplasms—a group of blood cancers—experienced worse outcomes from SARS-CoV-2 infection than the general population. The finding has implications for how hospitals manage immunocompromised cancer patients and inform clinical treatment decisions during future pandemic waves.

Originaltitel: Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry

Generera ett redaktionellt utkast på svenska